AU2001268053A1 - Human sparc-homologous (hsparc-h1) gene and methods and uses thereof - Google Patents

Human sparc-homologous (hsparc-h1) gene and methods and uses thereof

Info

Publication number
AU2001268053A1
AU2001268053A1 AU2001268053A AU6805301A AU2001268053A1 AU 2001268053 A1 AU2001268053 A1 AU 2001268053A1 AU 2001268053 A AU2001268053 A AU 2001268053A AU 6805301 A AU6805301 A AU 6805301A AU 2001268053 A1 AU2001268053 A1 AU 2001268053A1
Authority
AU
Australia
Prior art keywords
hsparc
homologous
gene
methods
human sparc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001268053A
Inventor
Pamela Jean Mitchell
Rosamund Carol Smith
Eric Wen Su
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU2001268053A1 publication Critical patent/AU2001268053A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU2001268053A 2000-07-05 2001-06-15 Human sparc-homologous (hsparc-h1) gene and methods and uses thereof Abandoned AU2001268053A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21621600P 2000-07-05 2000-07-05
US60/216,216 2000-07-05
PCT/US2001/014859 WO2002002771A2 (en) 2000-07-05 2001-06-15 Human sparc-homologous (hsparc-h1) gene and methods and uses thereof

Publications (1)

Publication Number Publication Date
AU2001268053A1 true AU2001268053A1 (en) 2002-01-14

Family

ID=22806217

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001268053A Abandoned AU2001268053A1 (en) 2000-07-05 2001-06-15 Human sparc-homologous (hsparc-h1) gene and methods and uses thereof

Country Status (2)

Country Link
AU (1) AU2001268053A1 (en)
WO (1) WO2002002771A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2513251C (en) 2003-01-14 2013-03-19 Dana-Farber Cancer Institute Cancer therapy sensitizer
US8420603B2 (en) 2004-05-14 2013-04-16 Abraxis Bioscience, Llc SPARC and methods of use thereof
AU2006249235B2 (en) 2004-05-14 2010-11-11 Abraxis Bioscience, Llc Sparc and methods of use thereof
WO2017070744A1 (en) * 2015-10-30 2017-05-04 Monash University Methods and compositions for improving glucose metabolism
US11691208B2 (en) 2018-10-27 2023-07-04 Ridge Tool Company Pipe cut-off tool and accessories for such tools

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002534055A (en) * 1998-05-14 2002-10-15 カイロン コーポレイション Human gene and gene expression product V
WO2001053455A2 (en) * 1999-12-23 2001-07-26 Hyseq, Inc. Novel nucleic acids and polypeptides
WO2000061755A2 (en) * 1999-04-09 2000-10-19 Chiron Corporation Secreted human proteins
AU2001239765A1 (en) * 2000-02-14 2001-08-27 Smith Kline Beecham Corporation Novel compounds
AU2001253362A1 (en) * 2000-04-13 2001-10-30 Smith Kline Beecham Corporation Novel compounds
JP2004519206A (en) * 2000-06-30 2004-07-02 インサイト・ゲノミックス・インコーポレイテッド Protein modification and conservative molecules

Also Published As

Publication number Publication date
WO2002002771A2 (en) 2002-01-10
WO2002002771A3 (en) 2003-01-23

Similar Documents

Publication Publication Date Title
AU2002314466A1 (en) Withasol and methods of use
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2002329759A1 (en) Methyltransferase genes and uses thereof
AU2002211717A1 (en) Stresscopins and their uses
AU2001288972A1 (en) Antipsychotic sulfonamide-heterocycles, and methods of use thereof
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU3072500A (en) Rhamnosyl-transferase gene and uses thereof
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU2002363938A1 (en) Methods and use of motoneuronotropic factors
AU2001263492A1 (en) 21956 and 25856, human aminopeptidases and uses thereof
AU2001264488A1 (en) Gene expression cassette and its use
AU2001268053A1 (en) Human sparc-homologous (hsparc-h1) gene and methods and uses thereof
AU2002341828A1 (en) Enhanced proteins and methods for their use
AU1894601A (en) Novel gene and use thereof
AU2002256556A1 (en) Sea-trosy and related methods
AU2001252062A1 (en) Steatosis-modulating factors and uses thereof
AUPQ760400A0 (en) Herbical formulations and methods of use thereof
AU2002355155A1 (en) Methods for gene disruption and uses thereof
AU2002240921A1 (en) Medane genes and proteins
AU2001231141A1 (en) Novel human septin and uses thereof
AU2002326718A1 (en) Tramdorins and methods of using tramdorins
AU2002245158A1 (en) Human proteins 55562 and 21617, and methods of use thereof
AU2001253669A1 (en) Human cadherin molecules and uses therefor
AU2002259238A1 (en) Dwf12 and mutants thereof
AU2002221222A1 (en) Novel method and use